Related by context. All words. (Click for frequent words.) 73 Troxatyl 70 histamine dihydrochloride 70 BRILINTA 70 acetonide FA 68 PROVENGE ® 68 OMAPRO ™ 67 Pruvel 67 MAGE A3 ASCI 67 Vectibix panitumumab 67 BrachySil TM 67 TBC# 67 Urocidin 67 Pafuramidine 67 Ceflatonin 67 histone deacetylase HDAC inhibitor 66 Ixempra 66 Iluvien TM 66 targeted radiotherapeutic 66 reslizumab 66 liposomal formulation 66 Frova ® 66 Fodosine 66 balsalazide tablet 66 Allovectin 7 66 DPX Survivac 66 Zenvia ™ 66 Peginterferon alfa 2b 66 GW# [003] 66 Ambrisentan 66 Inc. Nasdaq SGXP 66 Arranon 66 Arzerra ofatumumab 66 Zenpep 66 Nabi HB Intravenous 66 lintuzumab SGN 66 Actimmune ® 66 Initiate Clinical Trial 66 vosaroxin 66 Mepact 66 pediatric Crohn disease 66 Tarceva TM 66 SYCREST 66 Iluvien ® 66 intravenous acetaminophen 66 PrevOnco 66 Benlysta belimumab 65 Civacir 65 rasagiline tablets 65 PDX pralatrexate 65 Zybrestat 65 sorafenib Nexavar 65 omacetaxine mepesuccinate 65 Alzhemed TM 65 KRYSTEXXA TM pegloticase 65 Dacogen injection 65 oral prodrug 65 Panzem R 65 Archexin 65 HCl capsules 65 novel oral anticoagulant 65 Exherin 65 beta 1a 65 PDE4 inhibitor 65 Vertex hepatitis C 65 R sorafenib tablets 65 Omapro 65 Raptiva R 65 midstage clinical 65 sNDA submission 65 BEMA Granisetron 65 Aflibercept 65 CAMPATH 65 OvaRex ® MAb 65 amrubicin 65 Increlex TM 65 Pazopanib 65 molecular imaging radiopharmaceutical 65 oral salmon calcitonin 65 ILUVIEN ® 65 receptor tyrosine kinase inhibitor 65 UPLYSO 65 Annamycin 65 seliciclib CYC# 65 Orphan Status 65 Vitrasert R 65 MOVIPREP R 65 IL# PE#QQR 65 Proquin XR 65 oxymorphone ER 65 lumiliximab 65 CRTX 65 PANVAC VF 64 severe hypercholesterolemia 64 Xcytrin R 64 Orphan Designation 64 anticancer compound 64 RANK Ligand inhibitor 64 Bayer Onyx 64 markets HP Acthar 64 Sebivo 64 ruxolitinib 64 SNT MC# 64 naronapride 64 Saforis 64 phase IIb trial 64 Panzem R NCD 64 Amrubicin 64 BLA filing 64 Initiates Clinical 64 Receives Orphan Drug Designation 64 non nucleoside inhibitor 64 hoFH 64 IgG1 monoclonal antibody 64 delivers fluocinolone acetonide FA 64 TELINTRA 64 SinuNase ™ 64 alemtuzumab Campath 64 Onconase 64 FOR FURTHER INFORMATION ABOUT 64 forodesine hydrochloride 64 BENLYSTA ® 64 MyVax personalized immunotherapy 64 sNDAs 64 Aplidin 64 intranasal formulation 64 midstage trials 64 Evoltra ® 64 Retacrit 64 Orphan Drug designations 64 Evoltra TM 64 Esbriet ® 64 Emezine 64 pancreatic enzyme replacement 64 Evoltra 64 miconazole Lauriad 64 Personalized Immunotherapy 64 Nexavar ® 64 AVASTIN 64 LAF# 64 Submits Response 64 PHX# 64 Eliquis 64 interferon gamma 1b 64 Erbitux cetuximab 64 PROVENGE sipuleucel T 64 refractory APL 64 Vernakalant 64 RhuDex ® 64 Noxafil 64 TRX1 64 IMA# 64 Hedgehog antagonist 64 mitogen activated ERK kinase 64 Anidulafungin 64 Phase IIb clinical trials 64 Nexavar tablets 64 phase IIb clinical 64 Surfaxin LS 64 personalized immunotherapy 64 Somatuline Depot 64 SinuNase TM 64 Rebif ® 64 Pegloticase 64 AAG geldanamycin analog 64 Onco TCS 64 isoform selective 64 SANVAR 64 Ceplene histamine dihydrochloride 64 inhaled antibiotic 64 Fast Track Status 64 MAA submission 64 REBETOL combination therapy 64 HepeX B 64 acyclovir Lauriad R 64 torezolid phosphate 63 Onalta ™ 63 DPP4 inhibitor 63 Dabigatran etexilate 63 virus HCV protease inhibitor 63 Tracleer r 63 Aryplase 63 CRMD# 63 ZOLINZA 63 Granted Orphan Drug 63 HuMax CD4 63 thalidomide Thalomid 63 adalimumab Humira 63 vapreotide acetate 63 VALSTAR 63 mertansine 63 docetaxel Taxotere ® 63 orphan designation 63 PEG SN# 63 T Pred 63 EVIZON ™ 63 novel histone deacetylase 63 Irinotecan 63 Pirfenidone 63 COLAZAL R 63 investigational humanized monoclonal antibody 63 compound INCB# 63 Initiates Enrollment 63 generation purine nucleoside 63 rhIGF-I/rhIGFBP-3 63 Initiates Phase II 63 faropenem medoxomil 63 volociximab 63 Gleevec imatinib mesylate 63 regorafenib 63 gepirone ER 63 Files Investigational 63 Alimta pemetrexed 63 registrational 63 Cancidas 63 CAELYX 63 CINTREDEKIN BESUDOTOX 63 TOCOSOL Camptothecin 63 Romiplostim 63 sunitinib Sutent 63 Cloretazine ® 63 RSR# 63 herpetic keratitis 63 photoprotective drug 63 Soliris TM eculizumab 63 successfully commercialize Iluvien 63 Onrigin 63 refractory chronic lymphocytic 63 CCR5 antagonist 63 Soliris eculizumab 63 CDP# 63 apricitabine ATC 63 Ceplene TM 63 Panzem ® 63 Aroplatin 63 Velcade bortezomib 63 Trobalt 63 etanercept Enbrel 63 docetaxel Taxotere R 63 oral anti arrhythmic 63 Nasdaq SGEN 63 orBec 63 FOLOTYN ® 63 Phase #b/#a clinical 63 2 methoxyestradiol 63 GLP toxicology studies 63 Begins Dosing 63 Temsirolimus 63 Opterone R 63 Febuxostat 63 PS# DARA 63 Alkeran 63 thetreatment 63 ATHX 63 Marketing Authorisation Application 63 phase III isavuconazole 63 ONGLYZA ™ 63 histone deacetylase inhibitor 63 ISTODAX 63 Nipent R 63 Receives Fast Track 63 novel emulsion formulation 63 rilonacept 63 SPRYCEL ® 63 eritoran 63 TRISENOX ® 63 Cintredekin besudotox 63 lorvotuzumab mertansine 63 Oasmia 63 StemEx R 63 Gleevec Glivec 63 ORENCIA ® 63 Presents Preclinical 63 pain palliation 63 Votrient 63 Valtropin 63 Angiox ® 63 RTP #i 63 Taxotere docetaxel 63 HP Acthar Gel repository 63 opioid induced constipation OIC 63 TLK# 63 IV APAP 63 panitumumab Vectibix 63 oral ridaforolimus 63 Tykerb lapatinib 63 CAMPATH R 63 Raptiva ® 63 aerosolized AAT 63 Fx #A 63 Manja Bouman CEO 63 Firazyr 63 Torisel temsirolimus 62 immunotherapeutic vaccine 62 intravenous AAT 62 Targretin capsules 62 6R BH4 62 Vascular Wrap TM 62 Nasdaq ACHN 62 Fibrillex 62 Silodosin 62 MKC# MT 62 Daclizumab 62 motexafin gadolinium Injection 62 Panzem 62 Initiates Phase III 62 Presents Preclinical Data 62 Joulferon 62 Nivestim 62 Insegia 62 Deferiprone 62 Files IND 62 OMP designation 62 KIACTA ™ 62 LEP ETU 62 Receives Orphan Drug 62 PEG interferon 62 PF # [002] 62 VitiGam 62 miconazole Lauriad R 62 ixabepilone 62 TKPHF 62 Voraxaze 62 Vidaza R 62 targeted antifolate 62 ALN PCS 62 antibody MAb 62 Tocosol Paclitaxel 62 Zavesca R 62 glucocorticoid induced osteoporosis 62 Meritage Pharma 62 TASKi3 62 CEQ# 62 Xeloda ® 62 octreotide acetate 62 RIGScan CR 62 Proxinium TM 62 polysaccharide polymer 62 Teysuno 62 LymphoStat B TM 62 alefacept 62 proteasome inhibitor 62 dutogliptin 62 YONDELIS R 62 nalbuphine ER 62 alvespimycin 62 lucinactant 62 PREOS R 62 Zemiva TM 62 CVac 62 Mycamine 62 Pfizer Sutent 62 Simulect 62 VISICOL R 62 sitaxsentan 62 Kynapid 62 Prosaptide 62 ABILIFY ® 62 Nexavar sorafenib 62 Egrifta 62 CIP TRAMADOL ER 62 Unit Dose Budesonide 62 ELIQUIS 62 SILENOR 62 TYZEKA 62 Cloretazine 62 peripherally acting 62 Orphan designation 62 nucleoside analog 62 BiovaxID TM 62 vinorelbine tartrate 62 oral taxane 62 Q#IR 62 baminercept 62 PD LID 62 afamelanotide 62 Temodar ® 62 Phase Ib study 62 samalizumab 62 Ventrus 62 Sanvar R 62 Aviptadil 62 Memryte 62 ALTROPANE R 62 oral methylnaltrexone 62 Initiates Clinical Trial 62 sunitinib malate 62 Certolizumab pegol 62 Fibrillex TM 62 Zemplar Capsules 62 USL# 62 Certican 62 IND submission 62 drug ISA# 62 VNP#M 62 induced macular edema 62 JAK inhibitor 62 initiated Phase Ib 62 MNTX 62 inhaled AAT 62 Orapred ODT 62 NASDAQ REGN 62 Vidaza azacitidine 62 Phase IIIb clinical 62 DIFICID ™ 62 PSN# [001] 62 liprotamase 62 vinflunine 62 Myocet 62 triphendiol 62 Mipomersen 62 Amgen Prolia 62 Cethrin R 62 Advagraf 62 Evoltra R 62 Plicera 62 Hedgehog Pathway Inhibitor 62 phase IIa clinical 62 5 HT3 antagonist 62 AMEVIVE 62 ZACTIMA 62 MKC# MKC# PP 62 HEPLISAV TM 62 ZADAXIN ® 62 adenosine injection 62 IRX 2 62 sargramostim 62 Zavesca r 62 Phase IIb trials 62 Preos 62 candidate REP# 62 Glybera 62 PREOS 62 dexanabinol 61 TOCOSOL Paclitaxel 61 Spiegelmer ® 61 Collategene 61 Bosutinib 61 MyVax ® 61 trastuzumab DM1 61 Zenvia Phase III 61 elotuzumab 61 Arimidex anastrozole 61 CytoFab 61 Completes Patient Enrollment 61 Hexvix ® 61 NASDAQ CLSN 61 Pradefovir 61 subsidiaries visit http:/www.apricusbio.com 61 ATL# [001] 61 tubulin inhibitor 61 miconazole Lauriad ® 61 AzaSite Plus 61 Zorbtive TM 61 Campath ® 61 subcutaneous formulation 61 pregabalin Lyrica 61 R lenalidomide 61 Tasigna nilotinib 61 Nasdaq AVNR 61 radiation sensitizer 61 BCR ABL inhibitors 61 Zalbin 61 BrachySil 61 Rhucin R 61 SPL# Gel vaginal microbicide 61 telomerase inhibitor drug 61 Avastin bevacizumab 61 Junovan TM 61 RhuDex 61 Submits NDA 61 Entereg alvimopan 61 PrevOnco ™ 61 TOCOSOL 61 R adalimumab 61 aleglitazar 61 HuMax TAC 61 Vimpat ® lacosamide 61 Phenoptin 61 hypoxia activated prodrug 61 TEMODAL 61 EPCT 61 Kiacta 61 injectable formulations 61 valtorcitabine 61 lymphoid malignancies 61 sterile lidocaine patch 61 Chemophase 61 OvaRex R 61 alemtuzumab MS 61 Bicifadine 61 Sodium oxybate 61 phase IIb study 61 darinaparsin ZIO 61 arsenic trioxide injection 61 Plenaxis TM 61 LymphoStat B belimumab 61 INSPIRE Trial Phase III 61 XL# XL# 61 Successfully Completes Phase 61 Announces Poster Presentations 61 Linjeta TM 61 FACTIVE tablets 61 Factor VIIa 61 bosutinib 61 Announces Tentative Approval 61 Cardio Vascu Grow 61 PORxin TM 61 Phase Ib II 61 rALLy clinical trial 61 Luveris 61 LibiGel ® 61 Fast Track designations 61 metaglidasen 61 cetuximab Erbitux R 61 Afatinib 61 Tesmilifene 61 Gattex 61 dasatinib Sprycel ® 61 MAXY alpha 61 Arzerra TM 61 Nebido 61 metastatic carcinoid 61 NP2 Enkephalin 61 NV1FGF 61 Uplyso 61 MyVax 61 Anturol TM 61 OMAPRO 61 EOquin TM 61 phase Ib clinical 61 tanespimycin 61 leading oral taxane 61 Receives Positive Opinion 61 G#DT 61 vemurafenib 61 Clolar ® 61 polycythemia vera essential thrombocythemia 61 Anturol ® 61 Biologic License Application BLA 61 Pivotal Phase III 61 valopicitabine NM# 61 aripiprazole Abilify 61 Ceflatonin R 61 SUTENT ® 61 evaluating tivozanib 61 CONBRIZA 61 Cinryze ™ 61 autologous cellular immunotherapy 61 ATryn ® 61 lexidronam injection 61 sulodexide 61 gemcitabine Gemzar ® 61 Fludara ® 61 inhaled liposomal ciprofloxacin 61 Xifaxan rifaximin 61 developing Zerenex ferric 61 BIM #A# 61 Polymer Microspheres 61 BrachySil ™ 61 Hsp# Inhibitor 61 Huntexil 61 multi kinase inhibitor 61 JAK2 inhibitor 61 SYGNIS 61 vidofludimus 61 DCVax R 61 Firdapse 61 pharmacokinetic PK study 61 CA9 SCAN 61 Cimzia TM 61 Sprycel dasatinib 61 otelixizumab 61 severe gastroparesis 61 miconazole MBT 61 Omigard 61 DURIN TM 61 Navelbine R 61 alvimopan 61 AZILECT ® 61 biologic therapy 61 Zarnestra 61 Ketotransdel 61 BCG refractory 61 methylnaltrexone bromide 61 Generx TM 61 Meets Primary Endpoint 61 Dyloject TM 61 FIRMAGON R 61 GRALISE 61 CB2 selective receptor agonist 61 investigational therapies 61 desvenlafaxine 61 essential thrombocythemia ET 61 BLP# Liposome Vaccine 61 Telavancin 61 Ganciclovir 61 forodesine 61 IV acetaminophen 61 Gleevec imatinib 61 Junovan 61 Kissei Pharmaceutical 61 Somatuline R Autogel R 61 Phase 2b clinical trials 61 Levoleucovorin 61 telaprevir VX 61 Multaq dronedarone 61 Shigamabs ® 61 Achieves Primary Endpoint 61 selective modulator 61 dasatinib Sprycel 61 Harry Palmin President 61 Neuvenge 61 Alvesco R 61 Allovectin 7 ® 61 XYOTAX TM 61 Ciclesonide 61 Ocrelizumab 61 Genasense ® 61 OvaRex 61 AEGR 61 phase IIb III 61 HQK 60 romidepsin 60 Drug Eluting Stent System 60 Anavex #-# 60 SAR# [004] 60 Nexavar sorafenib tablets 60 Copegus ribavirin 60 investigational hepatitis C 60 Antisoma AS# 60 Amlodipine Besylate 60 selective A2A adenosine receptor 60 HCD# [002] 60 Orathecin 60 KRN# 60 HGS# 60 Gel repository corticotropin injection 60 docetaxel Injection Concentrate 60 Quinamed 60 PDE# inhibitors 60 Velac 60 humanised monoclonal antibody 60 Pyridorin 60 granted Orphan Designation 60 Submits IND 60 deforolimus 60 Pemetrexed 60 BYETTA ® 60 Orphan Drug Status 60 Orphan Drug status 60 REG2 60 APEX PD 60 topically applied SEPA 60 ORENCIA R 60 PSN# [002] 60 Marqibo TM 60 XL# anticancer compounds 60 liposomal doxorubicin 60 adult chronic ITP 60 Torisel 60 #D#C# 60 NerPharMa 60 Arimoclomol 60 IAP inhibitor 60 Dificid 60 investigational pharmacologically unique 60 Pulminiq 60 Phase Ib clinical 60 oropharyngeal candidiasis OPC 60 Removab 60 Ecallantide 60 Ventavis ® 60 fostamatinib 60 Augment ™ 60 Urocidin TM 60 Novartis Afinitor 60 Tezampanel 60 Regeneron Pharma 60 LE SN# 60 HCV RNA polymerase 60 candidate AQ4N 60 HepeX B TM 60 BCR ABL inhibitor 60 Triapine 60 brivaracetam 60 MGd 60 Nuvion 60 Glybera R 60 trastuzumab Herceptin R 60 AEterna 60 pan histone deacetylase 60 RhuDex TM 60 zolpidem tartrate sublingual tablet 60 Sudhir Agrawal D.Phil 60 orally administered inhibitor 60 cancer immunotherapies 60 novel prodrug 60 Trimesta 60 Initiates Phase 2b 60 Submits Investigational 60 EGS# 60 ENZON 60 Lambert Eaton Myasthenic 60 Generx ™ 60 Bayer Nexavar 60 PLK1 SNALP 60 Clofarabine 60 gefitinib Iressa 60 Phase III multicenter 60 investigational antiplatelet agent 60 PrandiMet 60 CYT# vascular disrupting 60 Inhalation Solution 60 ARIKACE ™ 60 REVLIMID lenalidomide 60 Aeroquin 60 PI3 kinase inhibitors 60 STELARA TM 60 NYSE Amex PTN 60 CeNeS Pharmaceuticals plc 60 Excellagen TM 60 cathepsin K inhibitor 60 Keppra ® XR 60 Augment Injectable 60 PEGylated anti 60 TORISEL TM 60 fosbretabulin 60 HalcyGen 60 IAP inhibitors 60 non nucleoside HCV 60 pralatrexate 60 therapeutic monoclonal antibody 60 MyVax R 60 Oncogenex 60 Kamada AAT 60 Satraplatin 60 KNS # 60 ACOMPLIA R 60 P#X# antagonist 60 diabetic neuropathic pain 60 MET inhibitor 60 Aclasta Reclast 60 Folotyn 60 Revlimid lenalidomide 60 casopitant 60 sorafenib tablets 60 Viramidine 60 Corlux 60 Potelligent Technology 60 immunomodulatory therapy 60 PRIALT 60 Hematide ™ peginesatide 60 IGF 1R inhibitor 60 liver resection surgeries 60 Risperidone Oral Solution 60 Maribavir 60 Saxagliptin 60 YONDELIS 60 orally inhaled migraine 60 Rhucin ® recombinant 60 Oracea TM 60 PGL# 60 ticagrelor Brilinta 60 Vilazodone 60 orphan medicinal product 60 #I TM# 60 radiotherapeutic 60 CIMZIA TM 60 AQ4N 60 Nasdaq VRTX today 60 registrational studies 60 Prestara 60 tramiprosate Alzhemed TM 60 Modrenal R 60 mesylate tablets approved 60 Roche Xeloda 60 Flutiform ™ 60 Loxapine 60 IRESSA 60 Premarket Approval 60 Octreolin 60 EOquin 60 Tramiprosate ALZHEMED TM 60 immunotherapeutic agent 60 Grants Orphan Drug 60 Multiple Ascending Dose 60 Camvia 60 Phase 1a clinical 60 Solasia 60 HuLuc# 60 Japanese Encephalitis Vaccine 60 highly purified pasteurized 60 Abiraterone acetate 60 Reclast Aclasta 60 cetuximab Erbitux 60 3 registrational trial 60 oral cladribine 60 ASX PGL 60 Campath alemtuzumab 60 tramiprosate ALZHEMED TM 60 PNP inhibitor 60 Novartis Galvus 60 Kosan dependence 60 Sutent sunitinib 60 incyclinide 60 demonstrated antitumor activity 60 efalizumab 60 Etravirine 60 HCV protease inhibitors 60 Guanilib 60 BiDil XR 60 Rezonic 60 SPARLON 60 GlycoPEG GCSF 60 PHASE III 60 ARIXTRA R 60 ezogabine 60 Zoraxel 60 Nasdaq CYCC Nasdaq CYCCP 60 Glufosfamide 60 granted orphan medicinal 60 Plenaxis R 60 Traficet EN 60 macitentan 60 oral picoplatin 60 ospemifene 60 Intravenous CP 60 L BLP# 60 Behcet uveitis 60 MGN# 60 phase Ib 60 Zerenex 60 HSP# inhibitor 60 GALNS 60 INCB# [001] 60 amifampridine phosphate 60 Laquinimod 60 Brilique 60 Trovax 60 ThermoDox R 60 novel therapeutic antibodies 60 donepezil hydrochloride 60 iii GTx 60 Vertex telaprevir 60 Cellegesic 60 dextromethorphan quinidine 60 treat chronic sinusitis 60 glucokinase activator 60 topical ophthalmic 60 Oracea ® 60 lintuzumab 60 Phase Ib clinical trials 60 Neo Kidney Augment 60 Dementia Related Psychosis 60 solanezumab 60 Stedesa 60 prokinetic agent 59 riociguat 59 Romidepsin 59 SEBIVO 59 JZP 59 BTG plc 59 Tasimelteon 59 biliary tract cancer 59 OTC Zegerid 59 axitinib 59 mitoxantrone plus 59 ACHN 59 FDA APPROVES 59 Zelnorm Zelmac 59 cystinosis patients 59 RoACTEMRA 59 Vascular Disrupting Agent 59 Afinitor everolimus 59 ATL# [002] 59 Surfaxin lucinactant 59 tafamidis 59 Celgene Revlimid 59 preclinical efficacy 59 mild vasodilator 59 oxypurinol 59 Movectro 59 FDA Accepts 59 Symbicort asthma 59 Omacetaxine 59 dirucotide MBP# 59 Aptivus ® 59 Entocort 59 Phase 1b clinical 59 Aloxi Injection 59 BN# [004] 59 Investigational Oral 59 mTOR inhibitor 59 Phase III TRIST 59 Cintredekin Besudotox 59 NUEDEXTA ™ 59 Kepivance 59 PROMACTA 59 IMiD 59 Roflumilast 59 TKM ApoB 59 DepoDur 59 Combidex 59 inhaled formulation 59 Addrenex 59 pafuramidine maleate 59 Zeneus 59 MDS AML 59 Aurexis 59 TransVax 59 Exherin TM 59 NOVARTIS 59 dermatology biopharmaceutical company 59 RezularTM 59 Iloperidone 59 TLR9 agonist 59 ELACYT 59 E1 INT TM 59 Telintra 59 drug GAP #B# 59 Dendreon Provenge 59 ALN TTR 59 TransVax tm 59 Dalbavancin 59 Phase 2b Clinical Trial 59 Roche Chugai 59 Davanat 59 small molecule chemotherapeutic 59 UCB Cimzia 59 bevacizumab Avastin ® 59 Oral NKTR 59 investigational monoclonal antibody 59 EVIZON TM squalamine lactate 59 Esbriet pirfenidone 59 Reports Preclinical Data 59 RhuDex R 59 teriflunomide 59 TransMID 59 ritonavir boosted danoprevir 59 REBETOL combination 59 secondary hyperparathyroidism 59 Nasdaq ONXX 59 ThermoDox ® 59 Liprotamase 59 SUCCEED trial 59 Degarelix 59 nephropathic cystinosis 59 OPTR 59 Zingo TM 59 cetuximab Erbitux ® 59 Submits Biologics License Application 59 Amplimexon 59 Orphan Drug designation 59 Restanza TM 59 myelodysplastic myeloproliferative diseases 59 SAR# [002] 59 AVP #D# 59 p# inhibitor 59 R sipuleucel T 59 Zensana 59 AMITIZA ® 59 Exenatide LAR 59 ONCONASE R 59 HGS ETR2 59 Bezielle 59 bendamustine 59 Vandetanib 59 Neurodex 59 Telzir 59 Dacogen decitabine 59 using VIAdel TM 59 Æterna Zentaris 59 Convivia TM 59 pseudobulbar affect PBA 59 GlaxoSmithKline plc GSK 59 Uvidem 59 EFAPROXYN 59 cannabinor 59 Nasdaq GENR 59 Apoptone 59 Matrix Phase 2b 59 eltrombopag 59 Granulocyte Colony Stimulating Factor 59 small molecule tyrosine 59 BioSante Pharmaceuticals Announces 59 NeoRx Corporation 59 ocrelizumab 59 SIR Spheres 59 DORIBAX 59 Orphan Medicinal Product 59 SomatoKine 59 Zerenex ™ 59 Rasilez HCT 59 Onalta 59 Lispro 59 E2F Decoy 59 outlicensed 59 LEVADEX ™ 59 Pertuzumab